DIANNE LIGA: Open Payments
NPI 1487878286 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 42 payments from 13 companies in 2025. Trend: 2023 $1,046 · 2024 $1,009 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 13 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $175 |
| Janssen Pharmaceuticals, Inc | 3 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Lundbeck LLC | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| ABBVIE INC. | 3 | $53 |
| Bausch Health US, LLC | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Tris Pharma Inc | 1 | $21 |
Products named: Qelbree, CAPLYTA, REXULTI, INVEGA SUSTENNA, VRAYLAR, APLENZIN, TRINTELLIX, FANAPT.
Industry payments across VA — which companies pay providers there.
